Treosulfan

CAS299-75-2EC206-081-0

Category

Other

Compound Class

n.a

Primary Use

Conditioning treatment prior to allogeneic hematopoietic stem cell transplantation

Treosulfan is an alkylating agent used as a conditioning treatment prior to allogeneic hematopoietic stem cell transplantation. It clears the bone marrow to make room for transplanted donor cells, and is administered together with fludarabine in both adults and children from one month of age with blood cancers or other severe disorders requiring a transplant.

Conditioning agent for allogeneic hematopoietic stem cell transplantationUsed in combination with fludarabine in blood cancer patientsUsed as a conditioning treatment for other severe disorders requiring bone marrow transplant

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 299-75-2

List This Product

Request This Product

Submit a request without registering